Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cancer cells often become addicted to signaling pathways like the mammalian target of rapamycin (mTOR) for sustained proliferation.
• Understanding the specific genetic dependencies of these addicted cells is crucial for developing targeted therapies.

Purpose of the Study:

• To identify genes essential for the proliferation of interleukin (IL)-3-independent, mTOR-addicted cancer cells.
• To uncover novel therapeutic targets by analyzing genes specifically required for transformed growth.

Main Methods:

• Conducted a genome-wide short hairpin RNA screen in a v-H-ras-transformed Pten-deficient cell line with distinct growth modes.
• Utilized a conditional lethal screen to identify genes required only in the absence of IL-3 (transformed growth mode).
• Validated hits through in silico analysis and rescreening in additional cancer cell lines.

Main Results:

• Identified 47 core genes essential for mTOR-addicted proliferation, including mTOR, mTOR complex 2 (mTORC2) component rictor, and several mitochondrial genes.
• Knockdown of these genes induced apoptosis in human cancer cell lines but not in normal fibroblasts.
• Highlighted the critical role of mitochondrial functions, including the respiratory chain and mitochondrial ribosome, in supporting cancer cell addiction.

Conclusions:

• mTORC2-addicted cancer cells exhibit a dependency on specific mitochondrial functions.
• These identified mitochondrial pathways represent potential novel drug targets for human cancer treatment.